Advertisement
more top stories »

Dementia

— Medical

Non-invasive Alzheimer's treatment restores memory using ultrasound

By - March 11, 2015 1 Picture
Alzheimer's disease is a chronic neurodegenerative disease that most often begins in people over 65 years of age. Usually it starts slowly and continues to worsen over time until the sufferer succumbs to an increasing loss of memory, bodily functions and, eventually, death. Research has shown that there is an association with Alzheimer's and the accumulation of plaques that affect the neuronal connections in the brain. Now researchers at the University of Queensland have discovered a new way to remove these toxic plaques using a non-invasive form of ultrasound therapy. Read More
— Medical

Scientists take a significant step towards an early warning blood test for Alzheimer's

By - July 10, 2014 1 Picture
An international collaboration of scientists led by King's College London (KCL) and Proteome Sciences plc has identified a combination of 10 proteins found in human blood cells which may lead to an accurate early warning test for Alzheimer's. An increased ability to detect this debilitating disease at an early stage has the potential to greatly improve quality of life and may even lead to new clinical trials developing new avenues of treatment designed to stop the disease in its tracks. Read More
— Science

Researchers uncover link between neurodegenerative diseases and molecular scaffold

By - June 4, 2014 1 Picture
Researchers from King's College London (KCL) claim to have uncovered a link between a molecular scaffold, that allows for interaction between key components of a cell, and the debilitating effects of neurodegenerative diseases. It is possible in the long term that this line of research will yield a new target for tailored treatment in the fight against devastating afflictions such as dementia and motor neuron disease. Read More
— Health and Wellbeing

New blood test predicts onset of Alzheimer's disease with 90% accuracy

By - March 9, 2014 1 Picture
US medical researchers have developed a blood test which predicts with 90 percent accuracy if an individual will develop Alzheimer's disease or mild cognitive impairment within three years. The test, which looks for a set of ten lipid markers, will allow treatments to be sought that may be effective during this early, asymptomatic stage of the disease. Read More
— Health and Wellbeing

Compound in fruits and vegetables prevents symptoms of Alzheimer's disease in mice

By - March 9, 2014 1 Picture
Alzheimer's disease represents the most common form of dementia, with the early stages of the disease generally characterized with short term memory loss and learning difficulties that increase in severity as the patient progresses in age. Scientists at the Salk Institute for Biological Studies, California, have discovered that with regular treatments of the antioxidant fisetin, they were able to prevent memory loss in mice with genetic mutations linked to Alzheimer's. Read More
— Health and Wellbeing

GPS app used to keep track of dementia patients

By - January 29, 2013 1 Picture
Researchers at Scandinavia’s largest research organization, SINTEFF, have been trialling a prototype GPS application to track dementia sufferers living at home, in institutions, and in other forms of shared accommodation facilities. The project has seen more than 50 dementia sufferers using the system for periods of up to a year and according to the researchers, people equipped with it felt safer, had more freedom to move around and enjoyed better quality of life. Read More

Subscribe to Gizmag's email newsletter

Advertisement